Genotypification and Predisposing Factors in Human Papilloma Virus Infection
NCT01924117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129
Last updated 2013-08-16
Summary
Objective: Determine the genotypes and risk factors associated with human papilloma virus infection in Mexican women.
Methods: It was a cross-sectional study of women attended at the Materno-Perinatal Hospital "Mónica Pretelini" and the Medical Research Center (CICMED), who were asked to complete a risk factor questionnaire and submitted to colposcopy to identify SIL. Cervical swab samples were obtained to perform linear array HPV genotyping test (Roche®, Mannheim, Germany).
Conditions
- Intraepithelial Neoplasia
Interventions
- OTHER
-
Linear Array HPV Genotyping assay
All samples with the suspicion of squamous intraepithelial lesion were processed with the Linnear Array methodology to identify HPV genotypes
Sponsors & Collaborators
-
Universidad Autonoma del Estado de Mexico
collaborator OTHER -
Materno-Perinatal Hospital of the State of Mexico
lead OTHER
Principal Investigators
-
Hugo Mendieta Zerón, PhD. · Universidad Autónoma del Estado de México
-
María del Carmen Colín Ferreyra, MSc. · Universidad Autónoma del Estado de México
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 15 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2011-05-31
- Completion
- 2011-10-31
More Related Trials
-
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
NCT07211204 ·Status: WITHDRAWN ·Phase: NA
-
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
NCT05282745 ·Status: RECRUITING
-
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
NCT04072913 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
NCT02045186 ·Status: TERMINATED ·Phase: NA
-
Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions
NCT00872937 ·Status: UNKNOWN
-
Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
NCT01289873 ·Status: COMPLETED
-
Prognostic Study of HPV Virus Integration in Women With HSIL
NCT05745597 ·Status: RECRUITING
-
Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination
NCT04909814 ·Status: COMPLETED
-
HPV Viral Load in Predicting the Prognosis of LSIL
NCT05051852 ·Status: RECRUITING
-
Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.
NCT04199260 ·Status: COMPLETED
-
Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015 ·Status: UNKNOWN ·Phase: NA
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
NCT00937950 ·Status: COMPLETED ·Phase: PHASE3
-
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort
NCT02774538 ·Status: COMPLETED ·Phase: NA
-
HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis
NCT06339684 ·Status: ACTIVE_NOT_RECRUITING
-
The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis
NCT00728871 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
NCT00877877 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
NCT06713655 ·Status: NOT_YET_RECRUITING
-
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
NCT01117389 ·Status: COMPLETED
-
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
NCT00892866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study
NCT05149248 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
NCT01837693 ·Status: COMPLETED ·Phase: NA
-
HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
NCT01984359 ·Status: COMPLETED ·Phase: NA
-
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635 ·Status: ACTIVE_NOT_RECRUITING